Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYou've got your first Wegovy pen and you're standing in the bathroom, instructions in hand, not entirely sure where to start. A demonstration video can bridge that gap — showing you the exact motion, the angle, the click, and how to confirm the dose has gone in. Wegovy (semaglutide) is a once-weekly subcutaneous injection licensed in the UK for weight management, and the technique is straightforward once you've seen it done. As a prescription-only medicine, it's supplied following a clinical assessment by a qualified prescriber, who can also guide you through any questions the video doesn't answer. The NHS semaglutide medicines page includes patient information that complements any visual guidance you find.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The question our prescribers hear regularly isn't "how do I do it", it's "will it hurt?" There's a common assumption that self-injecting means the kind of sharp sting associated with a blood test or vaccination. It doesn't. The Wegovy pen uses a very fine, short needle designed for the fatty tissue just under the skin, and most people describe the sensation as a brief pressure or pinch, sometimes nothing at all.
A good demonstration video shows you this reality rather than just narrating it. You'll see the pen uncapped, the needle cover removed, the skin pinched lightly (or not, depending on the site and personal preference), and the pen pressed firmly against the skin before the button is pressed. The key indicator that the dose has delivered is the window on the pen changing, from the dose number to zero, or from the marker moving fully. If you want to see exactly how that looks in practice, the Wegovy use video on this site shows the full sequence so watching it once tends to dissolve most of the anxiety.
If you want a thorough walkthrough of the full process, the Wegovy how-to video guide on this site covers the preparation steps in detail, from removing the pen from the fridge to disposing of it safely afterwards.
A proper demonstration walks through several distinct stages. First, preparation: the pen needs to reach room temperature before use (check your Patient Information Leaflet for the specific window), the label should be checked for the correct dose and expiry date, and hands should be clean. Then the injection site is selected (abdomen, outer thigh, or upper arm are all licensed sites) and if you're using alcohol swabs, the skin is cleaned and allowed to dry.
The injection itself involves removing the cap, pressing the pen flat and firmly against the skin (no tilting), pressing the button until you hear or feel a click, and holding it in place for the full count. That hold is important. Releasing too early can mean an incomplete dose. Once the indicator confirms delivery, the pen is withdrawn at the same angle it went in.
Disposal matters too. Used pens and needles go into a sharps container, the semaglutide administration video guide explains safe handling throughout. Pens should never go into household recycling or general waste.
For the precise technique details specific to your pen format, the Wegovy SmPC on the eMC is the authoritative source and is worth reading alongside any video.
Wegovy is available in multiple pen formats in the UK. The standard range covers doses from 0.25mg through to 2.4mg, titrated by your prescriber over several months. In April 2026 the MHRA approved a dedicated single-dose 7.2mg pen (a higher maintenance dose for adults with obesity (BMI 30 or above)) which has a slightly different design including an auto-dosing mechanism, a built-in covered needle that deploys automatically, and a lock after use.
This matters when you're watching a demonstration: a video recorded for the earlier pen format may not show the exact click sequence or window design of the 7.2mg pen. Look for demonstrations that match your specific pen, or ask your prescriber at our support line to clarify what you're looking at before your first injection.
The Wegovy treatment information page gives an overview of the licensed dose schedule, which your prescriber will follow based on your individual response.
A video can show you the mechanics perfectly and still leave some questions open. It won't tell you which injection site to choose if one area is bruised or irritated, how to handle a missed dose, or what to do if the pen window doesn't move after injection. Those situations belong with your prescriber, not a video.
The semaglutide video resource page covers some of the practical follow-up questions people raise after their first injection. And if you're still deciding whether Wegovy is the right option for you, the weight loss treatment overview compares the options licensed in the UK.
Side effects, particularly in the first few weeks, are worth knowing about before you start rather than after. Nausea, mild digestive discomfort and occasional fatigue are the most commonly reported effects, usually settling as your body adjusts. The NHS semaglutide page mentioned above lists these in full.
Questions about the cost of treatment are worth looking at separately, the Wegovy cost page sets out what private treatment involves and what a legitimate price should include.
When you're ready to have a clinical assessment and get your questions answered by a prescriber rather than a video, speak to our prescribers, consultations are free and reviewed the same day by a GPhC-registered Independent Prescriber.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.